Poland· PL-100009162

Bellergot

A medicinal product containing ergotamini tartras + atropinum + phenobarbitalum, registered in Poland by Wrocławskie Zakłady Zielarskie "Herbapol" S.A..

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedBellergotATC—REGISTER NO.PL-100009162PACKS LISTED1CHECKEDSeptember 27, 2026

The record

At a glance

URPL (Poland)
Active substance
Ergotamini tartras + Atropinum + Phenobarbitalum
Manufacturer
Wrocławskie Zakłady Zielarskie "Herbapol" S.A.
Country
Poland (PL)
ATC code
—
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909990336418

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9605bead-f69d-47fd-a807-caa5592e6933
GET /v1/drugs/9605bead-f69d-47fd-a807-caa5592e6933?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki drażowane",
  "source": "urpl",
  "strength": "0,3 mg + 0,1 mg + 20 mg",
  "packaging": "05909990336418 ¦ Rp ¦ 1773\n30 tabl.",
  "substance": "Ergotamini tartras 0.3 mg + Atropinum 0.1 mg + Phenobarbitalum 20 mg",
  "common_name": "Ergotamini tartras + Atropinum + Phenobarbitalum",
  "pl_product_id": "100009162",
  "pozwolenie_nr": "03364",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about ergotamini tartras + atropinum + phenobarbitalum.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.